@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL23111013115 a mbo:MassSpectrum ;
    dcterms:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms:date "2023-11-10"^^xsd:date ;
    dcterms:identifier "MSBNK-BAFG-CSL23111013115" ;
    dcterms:license <https://creativecommons.org/licenses/by-sa/4.0/> ;
    dcterms:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "50" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "13.11 min" ;
            mbo:solvent "A: Water 0.1% Formic acid, B: Acetonitrile 0.1% Formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Triclabendazole" ;
            mbo:ch_compound_class "Pharmaceutical" ;
            mbo:ch_exact_mass 3.579501e+02 ;
            rdfs:seeAlso cas:68786-66-3 ;
            schema:inChI "InChI=1S/C14H9Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3,(H,18,19)" ;
            schema:inChIKey inchikey:NQPDXQQQCQDHHW-UHFFFAOYSA-N ;
            schema:molecularFormula "C14H9Cl3N2OS" ;
            schema:name "Triclabendazole" ;
            schema:smiles "CSc1[nH]c2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2n1" ] ;
    mbo:has_peak [ mbo:intensity 1.13e+01 ;
            mbo:mz 1.630324e+02 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 28 ],
        [ mbo:intensity 5.1e+01 ;
            mbo:mz 2.509909e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 125 ],
        [ mbo:intensity 1.71e+01 ;
            mbo:mz 2.729891e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 42 ],
        [ mbo:intensity 4.079e+02 ;
            mbo:mz 2.739968e+02 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 2.21e+01 ;
            mbo:mz 2.759835e+02 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 54 ],
        [ mbo:intensity 2.39e+01 ;
            mbo:mz 2.769933e+02 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 59 ],
        [ mbo:intensity 1.2e+01 ;
            mbo:mz 2.809693e+02 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 29 ],
        [ mbo:intensity 1.5e+01 ;
            mbo:mz 3.079564e+02 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 37 ],
        [ mbo:intensity 4.54e+01 ;
            mbo:mz 3.089658e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 111 ],
        [ mbo:intensity 1.319e+02 ;
            mbo:mz 3.439342e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 323 ],
        [ mbo:intensity 3.25e+01 ;
            mbo:mz 1.650222e+02 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 80 ],
        [ mbo:intensity 2.96e+01 ;
            mbo:mz 1.709785e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 72 ],
        [ mbo:intensity 8.7e+00 ;
            mbo:mz 1.829771e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 21 ],
        [ mbo:intensity 8.8e+00 ;
            mbo:mz 1.969942e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 22 ],
        [ mbo:intensity 2.68e+01 ;
            mbo:mz 1.980021e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 66 ],
        [ mbo:intensity 7.29e+01 ;
            mbo:mz 1.989735e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 179 ],
        [ mbo:intensity 7e+00 ;
            mbo:mz 2.390264e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 17 ],
        [ mbo:intensity 3.64e+01 ;
            mbo:mz 2.420246e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 89 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz_value "358.9574"^^xsd:float ;
            mbo:precursor_type_value "[M+H]+" ] ;
    mbo:pk_num_peak 18 ;
    mbo:pk_splash "splash10-00di-0292000000-c6412e78146797a0a359" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "Triclabendazole; LC-ESI-QTOF; MS2; 50 V" .

